Drugs / ASP3291
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01320332 | Aug 2010 → Aug 2011 | ulcerative colitis | Telsar Pharma Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01612039 | Jul 2012 → Apr 2014 | ulcerative colitis | Telsar Pharma Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP3291 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01320332 ↗ |
| Route | Oral | “Oral tablets” NCT01320332 ↗ |